Others

How to Beat the Heat Using Your Calendar

July 5, 2023
Summer has arrived, and with it comes scorching temperatures. Despite the fact that some people enjoy the heat, others find it unbearable. Additionally, studies show that workplace productivity drops by…

Steering through venture’s global correction with the GPCA’s CEO

July 5, 2023

Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. This is our Wednesday show where we niche down to a single topic and dig deep. All the cool kids are filling out the Equity listener survey. We want to hear from you!  […]

Steering through venture’s global correction with the GPCA’s CEO by Theresa Loconsolo originally published on TechCrunch

The TechCrunch Disrupt 2023 July 4th sale ends today

July 5, 2023

Last call for price-savvy TechCrunchers! Our weeklong July 4th sale ends today! We resurrected our early bird for the occasion, and this is your final chance to score serious savings for TechCrunch Disrupt 2023, taking place on September 19–21 in San Francisco. July 4th sale on TechCrunch Disrupt 2023 passes ends today Need a reminder? […]

The TechCrunch Disrupt 2023 July 4th sale ends today by Lauren Simonds originally published on TechCrunch

Daniel Ek’s Neko Health raises $65M for preventative healthcare through full-body scans

July 5, 2023

Neko Health, the health tech startup co-founded by Spotify co-creator Daniel Ek, has raised €60 million ($65 million) in its first external round of funding. The Series A round was led by Lakestar, with participation from Atomico and General Catalyst. Founded out of Sweden in 2018 by Ek and Hjalmar Nilsonne, Neko Health exited stealth […]

Daniel Ek’s Neko Health raises $65M for preventative healthcare through full-body scans by Paul Sawers originally published on TechCrunch

PharmEasy seeks funding at a 90% valuation cut, report says

July 5, 2023

Indian online pharmacy startup PharmEasy has informed its existing investors that it plans to raise a new round of funding via rights issue at a 90% markdown from the previous valuation, Indian newspaper Economic Times reported Wednesday. PharmEasy, which earlier deferred a plan to go public, needs the new cash to pay its lender Goldman […]

PharmEasy seeks funding at a 90% valuation cut, report says by Manish Singh originally published on TechCrunch